BENSALEM, PA / ACCESSWIRE / February 26, 2020 / Law Offices of Howard G. Smith reminds investors of the upcoming March 23, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired of Geron Corporation ("Geron" or the "Company") (NASDAQ:GERN) investors who purchased common stock between March 19, 2018 and September 26, 2018, inclusive (the "Class Period").
Investors suffering losses on their Geron investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to [email protected].
On March 27, 2018, STAT published a report revealing that the Company's recent stock performance was due to "flimsy" claims in connection to the efficacy of imetelstat, Geron's experimental myelofibrosis treatment. STAT stated that the available data for imetelstat undercuts Geron's representations as to the drug's efficacy.
On this news, Geron's share price fell $1.75, or over 29%, over two consecutive trading sessions to close at $4.23 per share on March 27, 2018, thereby injuring investors.
Then, on September 27, 2018, Geron disclosed its Phase 2 study results for imetelstat failed to meet its primary efficacy endpoints.
On this news, Geron's share price fell $3.92, or over 62%, to close at $2.31 per share on September 27, 2018, thereby injuring investors further.
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that the Company had misled investors about the clinical study results for imetelstat; and (2) that as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times
If you purchased Geron securities during the Class Period, you may move the Court no later than March 23, 2020 to ask the Court to appoint you as lead plaintiff if you meet certain legal requirements. To be a member of the class action, you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to [email protected], or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
CONTACT:
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
[email protected]
www.howardsmithlaw.com
SOURCE: Law Offices of Howard G. Smith